Skip to main content

Prostate and Urologic Cancers

Conducts and supports research on the prevention and early detection of prostate and bladder cancers. Develops and supports prevention trials and evaluation of new agents, surrogate biomarkers, and emerging technologies for identifying premalignant lesions.

On This Page

All Heading 2s will automatically be pulled in to this list.
Do not edit the content on this template.

Major Programs

Staff List

Grid View

Photo	Name, Email, Phone	Room	Group(s)/Office
	Asefa, Mela mela.asefa@nih.gov 240-276-6422	5E328	Program Support Assistant \| Breast and Gynecologic Cancer Program Support Assistant \| Prostate and Urologic Cancer
	House, Margaret, RN, B.S.N. margaret.house@nih.gov 240-276-7047	5E306	Deputy Chief \| Prostate and Urologic Cancer
	Parnes, Howard L., M.D. howard.parnes@nih.gov 240-276-7045	5E302	Chief \| Prostate and Urologic Cancer

Grants

PI Name Sort descending	PI Organization	Title	Grant Number	Program Official
Judge, Andrew Robert	University Of Florida United States	The Complement System and Cancer Cachexia	5R01AR081648-04	Brandy Heckman-Stoddard, Ph.D., M.P.H.
Justilien, Verline	Mayo Clinic Jacksonville United States	ECT2 Isoform Switch in Pancreatic Cancer.	1R21CA296671-01	Matthew Young, Ph.D.
Kachnic, Lisa A.	Columbia University Health Sciences United States	Columbia University NCI Community Oncology Research Program	3UG1CA189960-11S1	Brandy Heckman-Stoddard, Ph.D., M.P.H.
Kahalley, Lisa Schum	Baylor College Of Medicine United States	Comparison of Symptom Burden/Toxicity, Neurocognitive Change, and Functional Outcomes in Pediatric Brain Tumor Patients Treated with Proton vs. Photon Radiotherapy.	3R01CA249988-05S3	Rachel Altshuler, Ph.D.
Kalpathy-Cramer, Jayashree	University Of Colorado Denver United States	AI algorithm development for cervical cancer screening in low resource settings	1R21CA305472-01	Nicholas Hodges, Ph.D.
Kanarek, Naama	Boston Children'S Hospital United States	Mechanistic Study of Methotrexate-Induced Oxidative Distress in Neurons and the CSF	5R01CA282477-02	John Clifford, Ph.D.
Kanetsky, Peter A	H. Lee Moffitt Cancer Ctr & Res Inst United States	A hybrid effectiveness-implementation trial to integrate precision skin cancer risk feedback in federally qualified health centers	5R01CA291735-02	Claire Zhu, Ph.D.
Kang, Dongkyun	University Of Arizona United States	Non-invasive, quantitative microscopic biomarkers for chemotherapy-induced peripheral neuropathy	1R01CA301271-01	Rachel Altshuler, Ph.D.
Kanwal, Fasiha	Baylor College Of Medicine United States	Risk Stratification for and Early Detection of Liver Cancer	5U01CA230997-08	Sidney Fu, M.D.
Kassie, Fekadu	University Of Minnesota United States	Targeting tumor cell mitochondria for the prevention and treatment of lung cancer	1R01CA285608-01A1
Kelleher, Sarah	Duke University United States	Initial Testing of a Mobile App Pain Coping Intervention for Outpatient Oncology Settings	5R21CA273832-02	Brennan Streck, Ph.D., RN, M.P.H.
Kelleher, Sarah	Duke University United States	Randomized Controlled Trial of a Hybrid-Delivered Cognitive Behavioral Symptom Management and Activity Coaching Intervention for Stem Cell Transplant Patients	5R01CA291888-02	Brennan Streck, Ph.D., RN, M.P.H.
Khan, Seema Ahsan	Northwestern University At Chicago United States	Northwestern Cancer Prevention Consortium	2UG1CA242643-07	Donald Johnsey
Khan, Seema Ahsan	Northwestern University At Chicago United States	Determinants of transdermal drug delivery to the normal and the radiated breast	5R01CA235647-05	Brandy Heckman-Stoddard, Ph.D., M.P.H.
Khasabov, Sergey G	University Of Minnesota United States	Treatment of cancer pain by lipid mediator Resolvin D1: role of Prostaglandin and Endocannabinoid signaling	5R01CA263777-05	Rachel Altshuler, Ph.D.